
Cipla to sell anti-viral drug remdesivir as Cipremi in India
Mumbai: Drug maker Cipla Limited on Sunday announced the launch of experimental anti-viral drug remdesivir under its brand name Cipremi. Remdesivir is the only US FDA approved Emergency Use Authorisation (EUA) …
Cipla to sell anti-viral drug remdesivir as Cipremi in India Read More